Daptomycin – a novel antibiotic against Gram-positive pathogens

Author： LaPlante Kerry L Rybak Michael J

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.11, 2004-11, pp. : 2321-2331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daptomycin - a novel antibacterial in the fight against resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Daptomycin: a novel agent for Gram-positive infections

By Tally F.P. Zeckel M. Wasilewski M.M. Carini C. Berman C.L. Drusano G.L. Oleson F.B.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1223-1238

Informa Healthcare

Access to resources Recommend Favorite

Molecular Mechanisms of Antibiotic Resistance in Gram-Positive Pathogens.

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 1, 2001-05 ,pp. : 63-77

Bentham Science Publishers

Access to resources Recommend Favorite

Daptomycin - a new option for resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections

By Eisenstein Barry I

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1159-1169

Informa Healthcare

Access to resources Recommend Favorite